It was applied to mutant APPswe mRNA silencing without altering the wild-type APP mRNA in Alzheimer’s disease to show strong inhibition of pathologies while showing the power of silencing one “toxic” gene and expressing a second “protective” gene by a single AAV vector. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.